1994
DOI: 10.1002/jcp.1041580303
|View full text |Cite
|
Sign up to set email alerts
|

Requirement for receptor‐bound urokinase in plasmin‐dependent cellular conversion of latent TGF‐β to TGF‐β

Abstract: The role of receptor-bound urokinase-type plasminogen activator (uPA) in cellular activation of latent transforming growth factor-beta (LTGF-beta) was investigated in a model system of mouse LB6 cells transfected with either a human uPA receptor cDNA (LhuPAR+), a human prouPA cDNA (LhuPA), or a control neomycin-resistance cDNA (Lneo). When LhuPAR+ cells were co-cultured with LhuPA cells, the plasmin-dependent fibrinolytic activity generated was more than that observed in either homotypic cultures with fivefold… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

6
86
0

Year Published

1997
1997
2009
2009

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 168 publications
(92 citation statements)
references
References 45 publications
(60 reference statements)
6
86
0
Order By: Relevance
“…T cells produce TGF-␤ as a latent precursor that needs to be converted into a biologically active form (46,47,50). Activated T cells express the urokinase plasminogen activator receptor that converts latent to active TGF-␤1 and IL-2 up-regulates this activity (51,52). Thus, one function of IL-2 could be to support the constant source of active TGF-␤ that is needed to maintain Treg Foxp3 expression.…”
Section: Discussionmentioning
confidence: 99%
“…T cells produce TGF-␤ as a latent precursor that needs to be converted into a biologically active form (46,47,50). Activated T cells express the urokinase plasminogen activator receptor that converts latent to active TGF-␤1 and IL-2 up-regulates this activity (51,52). Thus, one function of IL-2 could be to support the constant source of active TGF-␤ that is needed to maintain Treg Foxp3 expression.…”
Section: Discussionmentioning
confidence: 99%
“…Urokinase acts by degradation of pericellular matrix, because of proteolytic cascade focused on cell surface leading to plasmin generation and matrix metalloprotease activation (Andreasen et al, 1997) but also by an increased cell migration independent of proteolysis (Silvestri et al, 2002). In addition, in relation to plasmin formation, uPA activates latent growth factors and releases growth factors bound to extracellular matrix (Odekon et al, 1994;Ribatti et al, 1999).…”
Section: Discussionmentioning
confidence: 99%
“…Further studies are needed to reveal the specific mechanism by which plasmin suppresses macrophage accumulation in tumors, but two likely possibilities include the proteolytic activation of growth factors and the proteolytic modification of the extracellular matrix (Rifkin et al, 1999;Werb, 1997). Transforming growth factor-b1 is a powerful suppressor of inflammatory cell recruitment to tissues, and its proteolytic release from the latent transforming growth factor-b binding protein has been linked to plasmin (Kulkarni et al, 1993;Odekon et al, 1994;Sato et al, 1990;Shull et al, 1992). Many cell types, including monocytes/macrophages, have specific receptors for fibrin and fibrin degradation products, and plasmin-generated fibrin degradation products have been reported to have immunosuppressive properties (Plow and Edgington, 1986;Simon et al, 1993).…”
Section: Discussionmentioning
confidence: 99%